Cellular Immunotherapies for Solid Tumors Digital Summit

Temas de la conferencia
The cell therapy revolution has changed the face of cancer treatments providing potentially curative therapy for patients which had few options left. However, there is still more to do in the field.

Currently, 90% of all cancers arise from solid tumors, yet extremely little efficacy has been shown with cellular immunotherapies, despite their curative success in liquid tumors. Therefore, the time has come to invest in uncovering the nuances of solid tumor biology.

Destinatario
1000

Organizador profesional (PCO)
Hanson Wade

Observaciones
Brochure: https://go.evvnt.com/668806-3?pid=4832

Speakers: Robin Parihar, Baylor College of Medicine, Benjamin Rengstl, BioNTech Cell and Gene Therapies GmbH, Michael Klichinsky, Carisma Therapeutics & more.

https://go.evvnt.com/668806-1?pid=4832

Mr. Jessica Durston